ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 639517 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 639517; 2) Community: the network communities that were significantly associated with the response to NSC 639517; 3) Molecule: the relationships between components within communities and NSC 639517; 4) MDR: the compounds that were significantly associated with the NSC 639517.

NSC Compound Enrichment Correlation
NSC 718781 Erlotinib hydrochloride 0.0236268253072453 -0.17249398
NSC 726089 11-(4-dimethylaminobenzyliden)-8-methoxy-5-methyl-11H-indolo [1,2-b]indazolium trifluoromethanesulfonate 0.0236268253072453 0.469414
NSC 743433 8-(4-{4-[6-(4-piperazinoquinazoline)-7-methoxy-2,3,5,11-atetrahydra-1H-benzo[e]pyrrolo[1,2-c][1,4]diazepin-5-one 0.0236268253072453 0.54946274
NSC 100290 Doxypyrromycin hydrochloride 0.0246753314031138 0.25087755
NSC 10466 Aizen Magenta 0.0246753314031138 0.25381316
NSC 116693 Null 0.0246753314031138 0.26592923
NSC 13317 Null 0.0246753314031138 0.483922
NSC 134754 Null 0.0246753314031138 0.42972193
NSC 145168 1H-Pyrrole-2,5-dione, 1-(1-hydroxy-2-oxopropyl)- 0.0246753314031138 0.69855413
NSC 243022 Cinerubin A hydrochloride 0.0246753314031138 0.18781365
Total:70  Current:41    [First] [Prev] [Next] [Last]